A rapid immunosensor was developed to assess the homeostasis of Ca2+ metabolism.
CBP undergone conformation change upon Ca2+ binding was discriminated using antibody.
2-D chromatography was used to analyze serum Ca2+ in a clinical range of 0.25–2.5 mM.
This inspired us to further investigate a dual-immunoassay system for Ca2+ and PTH.